LLY
Eli Lilly and Company
NYSEUSDEQUITY
DELAYED
Last price
1,254.15
▲ 9.75 (0.78%)
MARKET · —
Price
Open
1,249.63
Prev close
1,244.40
Day high
1,271.22
Day low
1,230.00
Volume
1.88M
Market cap
—
P/E (TTM)
—
52W range
694.23 – 1,292.65
Trailing performance
Returnvs SPY
1W
+6.38%
+7.7%
1M
+5.86%
+2.1%
3M
+20.52%
+17.4%
6M
+24.36%
+13.3%
YTD
+16.82%
+4.5%
1Y
+77.96%
+58.0%
3Y
+129.83%
+55.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1,224.54
+2.42% from price
SMA 20
1,198.10
+4.78% from price
SMA 50
1,179.58
+6.43% from price
SMA 100
1,083.99
+15.70% from price
SMA 200
1,052.98
+19.22% from price
EMA 12
1,220.51
+2.76% from price
EMA 26
1,199.73
+4.54% from price
EMA 50
1,169.64
+7.23% from price
RSI (14)
59.4
Neutral
MACD (12,26,9)
20.78
Hist 6.39
ATR (14)
45.25
3.60% of price
Realised vol 30D
35.5%
Annualised
Bollinger upper
1,280.74
20, 2σ
Bollinger lower
1,115.46
20, 2σ
50 / 200 cross
Golden
1,179.58 vs 1,052.98
Trend bias
Above 200
+19.22%
Risk profile
Beta vs SPY
0.34
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
35.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-23.3%
Peak to trough
Max drawdown 5Y
-34.8%
Peak to trough
ATR 14
45.25
3.60% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Will Eli Lilly’s Global Vault CRM Deal and Leadership Shift Change Veeva Systems’ (VEEV) Narrative?
Simply Wall St. · 59m ago
Eli Lilly (LLY) Is Up 6.4% After UK Clears Foundayo and GLP‑1 Portfolio Advances - What's Changed
Simply Wall St. · 5h ago
Eli Lilly Jumps as Weight-Loss Leadership Drives Another Breakout
GuruFocus.com · 13h ago
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK
Insider Monkey · 14h ago
Lilly's Multiple Assumes Less Growth Than You Think
Trefis · 14h ago
Most Of What Moves AbbVie Stock Has Nothing To Do With The Market
Trefis · 15h ago
Stock Split Watch: Is Eli Lilly (LLY) Stock Next?
Motley Fool · 18h ago
Apple paid $17bn in taxes to Ireland after court ruling on back levies
Financial Times · 21h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.